Seminars in Roentgenology
Volume 43, Issue 1 , Pages 29-38 , January 2008

Inflammatory Bowel Disease: Imaging of the Pediatric Patient

  • Erika H. Mann, BSc, MD, FRCP(C)

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Erika H. Mann, BSc, MD, FRCP(C), Staff Radiologist, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada, L6J 7J1.

References 

  1. Hyams JS. Inflammatory bowel disease. Pediatr Rev. 2000;21:291–295
  2. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet. 2001;357:1093–1094
  3. Murch SH, Baldassano R, Buller H, et al. Inflammatory bowel disease: Working Group report of the second World Congress of Paediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr Gastroenterol Nutr. 2004;39(suppl):647–654
  4. Diefenbach KA, Breuer CK. Paediatric inflammatory bowel disease. World J Gastroenterol. 2006;12:3204–3212
  5. Baldassano RN, Piccoli DA. Inflammatory bowel disease in paediatric and adolescent patients. Gastroenterol Clin North Am. 1999;28:445–448
  6. Grand RJ, Homer DR. Approaches to inflammatory bowel disease in childhood and adolescence. Pediatr Clin North Am. 1975;22:835–850
  7. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002;122:867–874
  8. Fiocchi D. Inflammatory bowel disease: aetiology and pathogenesis. Gastroenterology. 1998;115:182–205
  9. Hyams JS, Markowitz JF. Can we alter the natural history of Crohn disease in children?. J Pediatr Gastroenterol Nutr. 2005;40:262–272
  10. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serology assays in paediatric inflammatory bowel disease. Gastroenterology. 1998;115:822–829
  11. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:255–281
  12. Nishiwaki T, Ina K, Goto H, et al. Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease. J Gastroenterol. 2005;40:128–136
  13. Mamula P, Markowitz JE, Baldassano RN. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am. 2003;32:967–995
  14. Motil KJ, Grand RJ, Davis-Kraft L, et al. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology. 1993;105:681–691
  15. Walker-Smith JA. Clinical and diagnostic features of Crohn’s disease and ulcerative colitis in childhood. Baillieres Clin Gastroenterol. 1994;8:65–81
  16. Griffiths AM, Buller HB. Inflammatory bowel disease. In:  Walker WA,  Durie PR,  Hamilton JR editor. Pediatric gastrointestinal disease (Pathophysiology, Diagnosis, Management). (ed 2). Hamilton, ON: BC Decker Inc; 2000;p. 613–651
  17. Halligan S, Nicholls S, Bartram CI, et al. The distribution of small bowel Crohn’s disease is children compared to adults. Clin Radiol. 1994;49:314–316
  18. Chong SKF, Blackshaw AJ, Boyle S, et al. Histological diagnosis of chronic inflammatory bowel disease in childhood. Gut. 1985;26:55–59
  19. Kelts DG, Grand RJ. Inflammatory bowel disease in children and adolescents. Curr Probl Pediatr. 1980;10:1–40
  20. Abdullah BA, Gupta SK, Croffie JM, et al. The role of esophagogastroduodenoscopy in the initial evaluation of childhood inflammatory bowel disease: a 7-year study. J Pediatr Gastroenterol Nutr. 2002;35:636–640
  21. Mashako MN, Cezard JP, Navarro J, et al. Crohn’s disease lesions in the upper gastrointenstinal tract: correlation between clinical radiological, endoscopic and histological features in adolescents and children. J Pediatr Gastroenterol Nutr. 1989;8:442–446
  22. Rajwal SR, Puntis JW, McClean P, et al. Endoscopic rectal sparing in children with untreated ulcerative colitis. J Pediatr Gastroenterol Nutr. 2004;38:66–69
  23. Glickman JN, Bousavaros A, Farraye FA, et al. Paediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004;28:190–197
  24. Sharif F, McDermott M, Dillon M, et al. Focal enhanced gastritis in children with Crohn’s disease and ulcerative colitis. Am J Gastroenterol. 2002;97:1415–1420
  25. Kundhal PS, Stormon MO, Zachos M, et al. Gastral antral biopsy in the differentiation of paediatric colitides. Am J Gastroenterol. 2003;98:557–561
  26. Guilhon de Araujo Sant’Anna AM, Dubois J, Miron MC, et al. Wireless capsule endoscopy for obscure small-bowel disorders: Final results of the first paediatric controlled trial. Clin Gastroenterol Hepatol. 2005;3:264–270
  27. Bremner AR, Pridgeon J, Fairhurst J, et al. Ultrasound scanning may reduce the need for barium radiology in the assessment of small-bowel Crohn’s disease. Acta Paediatr. 2004;93:479–481
  28. Sarrazin J, Wilson SR. Manifestations of Crohn disease at US. Radiographics. 1996;16:499–520
  29. Faure C, Belarbi N, Mougenot JF, et al. Ultrasonographic assessment of inflammatory bowel disease in children: comparison with ileocolonoscopy. J Pediatr. 1997;130:147–151
  30. Bremner AR, Griffiths M, Argent JD, et al. Sonographic evaluation of inflammatory bowel disease: a prospective, blinded comparative study. Pediatr Radiol. 2006;36:947–953
  31. Spalinger J, Patriquin H, Miron MC, et al. Coppler US in patients with Crohn’s disease: vessel density in the diseased bowel reflects disease activity. Radiology. 2000;217:787–791
  32. Herlinger H. A modified technique for the double contrast small bowel enema. Gastrointest Radiol. 1978;3:201–207
  33. Laufer L, Hamilton JD. The radiological differentiation between ulcerative and granulomatous colitis by double contrast radiology. Am J Gastroenterol. 1976;66:259–269
  34. Stringer DA. Imaging inflammatory bowel disease in the pediatric patient. Radiol Clin North Am. 1987;25:93–113
  35. Gore RM, Balthazar EJ, Ghahremani GG, et al. CT features of ulcerative colitis and Crohn’s disease. Am J Roentgenol. 1996;167:3–15
  36. Jamieson DH. Abdominal CT: clear fluids can replace water soluble oral contrast media. Pediatr Radiol. 2002;32:462–463
  37. Gore RM. CT of inflammatory bowel disease. Radiol Clin North Am. 1989;27:717–729
  38. Herlinger H, Furth EE, Rubesin SE. Fibrofatty proliferation of the mesentery in Crohn disease. Abdom Imaging. 1998;23:446–448
  39. Del Campo L, Arribas I, Valbuena M, et al. Spiral CT findings in active and remission phases in patients with Crohn Disease. J Comput Assist Tomogr. 2001;25:792–797
  40. Meyers MA, McGuire PV. Spiral CT demonstration of hypervascularity in Crohn disease: “vascular jejunization of the ileum” or the “comb sign”. Abdom Imaging. 1995;20:327–332
  41. Wall BF, Hart D. Revised radiation doses for typical-ray examinations. Br J Radiol. 1997;70:437–439
  42. Morgan HT. Dose reduction for CT pediatric imaging. Pediatr Radiol. 2002;32:724–728
  43. Hall EJ. Lessons we have learned from our children: cancer risks for diagnostic radiology. Pediatr Radiol. 2002;32:700–706
  44. Mang T, Graser A, Schima W, et al. CT colonography: Techniques, indications, findings. Eur J Radiol. 2007;61:388–399
  45. Shoenut JP, Semelka RC, Silverman R, et al. Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol. 1993;17:73–78
  46. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology. 1999;212:876–884
  47. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. MR enteroclysis protocol optimization: comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences. Eur Radiol. 2001;11:908–913
  48. Laghi A, Paolantonia P, Passariello R. Small Bowel Magn Reson Imaging. Clin N Am. 2005;13:331–348
  49. Barkhausen J, Quick HH, Lauenstein T, et al. Whole-body MR imaging in 30 seconds with real-time true FISP and a continuously rolling table platform: feasibility study. Radiology. 2001;220:252–256
  50. Darbari A, Sena L, Argani P, et al. Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD. Inflamm Bowel Dis. 2004;10:67–72
  51. Shoenut JP, Semelka RD, Magro CM, et al. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol. 1994;19:31–35
  52. Laghi A, Borrelli O, Paolantonio P, et al. Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn’s disease. Gut. 2003;52:393–397
  53. Magnano G, Granata C, Barabino A, et al. Polyethylene glycol and contrast-enhanced MRI of Crohn’s disease in children: preliminary experience. Pediatr Radiol. 2003;33:385–391
  54. Pauls S, Gabelmann A, Schmidt SA, et al. Evaluating bowel wall vascularity in Crohn’s disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound. Eur Radiol. 2006;16:2410–2417
  55. Ros PR, Steinman RM, Torres GM, et al. The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers. Am J Roentgenol. 1991;157:761–767
  56. Li KC, Tart RP, Fitzsimmons JR, et al. Barium sulphate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies. Magn Reson Imaging. 1991;9:141–150
  57. Boraschi P, Braccini G, Gigoni R, et al. MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: an open phase III trial. Magn Reson Imaging. 2004;22:1085–1095
  58. Masselli G, Casciani E, Polettini E, et al. Assessment of Crohn’s disease in the small bowel: prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis. Eur Radiol. 2006;16:2817–2827
  59. Wiarda BM, Kuipers EJ, Heitbrink MA, et al. MR enteroclysis of inflammatory small-bowel diseases. Am J Roentenol. 2006;187:522–531
  60. Friedman S. General principles of medical therapy of inflammatory bowel disease. Gastroenterol Clin North Am. 2004;33:191–198
  61. Kohli R, Melin-Aldana H, Sentongo TA. Mesalamine-induced pneumonitis during therapy for chronic inflammatory bowel disease: a pediatric case report. J Pediatr Gastroenterol Nutr. 2005;41:479–482
  62. Sentongo TA, Piccoli DA. Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature. J Pediatr Gastroenterol Nutr. 1998;27:344–347
  63. Wallis RS, Broder M, Wong J, et al. Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis. 2005;41(suppl):194–198
  64. Kolho KL, Ruuska T, Savilahti E. Severe adverse reactions to infliximab therapy are common in young children with inflammatory bowel disease. Acta Paediatr. 2007;96:128–130
  65. Esteve M, Saro C, Gonzalez-Huix F, et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis. Gut. 2004;53:1363–1365
  66. Terdiman JP, Steinbuch M, Blumentals WA, et al. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:367–371
  67. Friedman S. Cancer in Crohn’s disease. Gastroenterol Clin North Am. 2006;35:621–639
  68. Kerber GW, Frank PH. Carcinoma of the small intestine and colon as a complication of Crohn disease: Radiologic manifestations. Radiology. 1984;150:639–645

PII: S0037-198X(07)00063-6

doi: 10.1053/j.ro.2007.08.005

Seminars in Roentgenology
Volume 43, Issue 1 , Pages 29-38 , January 2008

Article Tools

* Image Usage & Resolution